-
1
-
-
0042392072
-
Mechanisms of the antinociceptive effect of subcutaneous Botox®: Inhibition of peripheral and central nociceptive processing
-
Cui M, Li Z, You S, Khanijou S, Aoki KR. Mechanisms of the antinociceptive effect of subcutaneous Botox®: Inhibition of peripheral and central nociceptive processing. Arch Pharmacol 2002, 365:33.
-
(2002)
Arch Pharmacol
, vol.365
, pp. 33
-
-
Cui, M.1
Li, Z.2
You, S.3
Khanijou, S.4
Aoki, K.R.5
-
2
-
-
0346094286
-
Subcutaneous administration of botulinum toxin A reduces formalin-induced pain
-
Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 2004, 107(1-2):125-33.
-
(2004)
Pain
, vol.107
, Issue.1-2
, pp. 125-133
-
-
Cui, M.1
Khanijou, S.2
Rubino, J.3
Aoki, K.R.4
-
3
-
-
0042232400
-
Evidence for antinociceptive activity of botulinum toxin type A in pain management
-
suppl
-
Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache 2003, 43(1):S9-15. suppl
-
(2003)
Headache
, vol.43
, Issue.1
-
-
Aoki, K.R.1
-
4
-
-
23644431890
-
Botulinum toxin and intractable trigeminal neuralgia
-
Türk U, Ilhan S, Alp R, Sur H. Botulinum toxin and intractable trigeminal neuralgia. Clin Neuropharmacol 2005, 28(4):161-2.
-
(2005)
Clin Neuropharmacol
, vol.28
, Issue.4
, pp. 161-162
-
-
Türk, U.1
Ilhan, S.2
Alp, R.3
Sur, H.4
-
5
-
-
33644764814
-
Botulinum toxin A relieved neuropathic pain in a case of post-herpetic neuralgia
-
Liu HT, Tsai SK, Kao MC, Hu JS. Botulinum toxin A relieved neuropathic pain in a case of post-herpetic neuralgia. Pain Med 2006, 7(1):89-91.
-
(2006)
Pain Med
, vol.7
, Issue.1
, pp. 89-91
-
-
Liu, H.T.1
Tsai, S.K.2
Kao, M.C.3
Hu, J.S.4
-
6
-
-
13144283667
-
Botulinum toxin type A in experimental neuropathic pain
-
Bach-Rojecky L, Relja M, Lackovic Z. Botulinum toxin type A in experimental neuropathic pain. J Neural Transm 2005, 112(2):215-19.
-
(2005)
J Neural Transm
, vol.112
, Issue.2
, pp. 215-219
-
-
Bach-Rojecky, L.1
Relja, M.2
Lackovic, Z.3
-
7
-
-
33846882356
-
Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain
-
Luvisetto S, Marinelli S, Cobianchi S, Pavone F. Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain. Neuroscience 2007, 145(1):1-4.
-
(2007)
Neuroscience
, vol.145
, Issue.1
, pp. 1-4
-
-
Luvisetto, S.1
Marinelli, S.2
Cobianchi, S.3
Pavone, F.4
-
8
-
-
0036840028
-
A focused review on the use of botulinum toxins for neuropathic pain
-
suppl
-
Argoff CE. A focused review on the use of botulinum toxins for neuropathic pain. Clin J Pain 2002, 18(6):S177-81. suppl
-
(2002)
Clin J Pain
, vol.18
, Issue.6
-
-
Argoff, C.E.1
-
9
-
-
0042632941
-
Botulinum toxin A improved burning pain and allodynia in two patient with spinal cord pathology
-
Jabbari B, Maher N, Difazio MP. Botulinum toxin A improved burning pain and allodynia in two patient with spinal cord pathology. Pain Med 2003, 4(2):206-10.
-
(2003)
Pain Med
, vol.4
, Issue.2
, pp. 206-210
-
-
Jabbari, B.1
Maher, N.2
Difazio, M.P.3
-
10
-
-
54849435847
-
Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain
-
Ranoux D, Attal N, Morain F, Bouhassira D. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 2008, 64(3):274-83.
-
(2008)
Ann Neurol
, vol.64
, Issue.3
, pp. 274-283
-
-
Ranoux, D.1
Attal, N.2
Morain, F.3
Bouhassira, D.4
|